Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition

Methotrexate is used to treat autoimmune diseases and malignancies, including acute lymphoblastic leukemia (ALL). Inter-individual variation in clearance of methotrexate results in heterogeneous systemic exposure, clinical efficacy, and toxicity. In a genome-wide association study of children with A...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Genome research Ročník 22; číslo 1; s. 1
Hlavní autoři:	Ramsey, Laura B, Bruun, Gitte H, Yang, Wenjian, Treviño, Lisa R, Vattathil, Selina, Scheet, Paul, Cheng, Cheng, Rosner, Gary L, Giacomini, Kathleen M, Fan, Yiping, Sparreboom, Alex, Mikkelsen, Torben S, Corydon, Thomas J, Pui, Ching-Hon, Evans, William E, Relling, Mary V
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 01.01.2012
Témata:	Adolescent Antimetabolites, Antineoplastic - administration & dosage Antimetabolites, Antineoplastic - pharmacokinetics Child Child, Preschool Clinical Trials as Topic Cohort Studies Exons Female Haplotypes Humans Infant Male Methotrexate - administration & dosage Methotrexate - pharmacokinetics Neoplasm Proteins - genetics Neoplasm Proteins - metabolism Organic Anion Transporters - genetics Organic Anion Transporters - metabolism Pharmacogenetics - methods Polymorphism, Single Nucleotide Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism Solute Carrier Organic Anion Transporter Family Member 1b1
ISSN:	1549-5469, 1549-5469
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!